| Dietary Advanced Glycation End-Products (dAGE) and Prostate Cancer |
Susan Steck |
University of South Carolina |
PLCO |
Feb 13, 2026 |
PLCO-2021 |
| Bone Marrow Extracellular Matrix Gene Expression Analysis for Cancer Prognosis and Bone Metastasis Prediction: An 82-Gene Panel Study Using PLCO Trial Data |
Shelly Peyton |
Trustees of Tufts College |
PLCO |
Feb 4, 2026 |
PLCO-2011 |
| Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods, and causal survival models |
Hansapani Rodrigo |
University of Texas Rio Grande Valley |
PLCO |
Feb 4, 2026 |
PLCO-2015 |
| Epstein-Barr virus-associated neo-antigens in advanced prostate cancer |
Denong Wang |
SRI International |
PLCO |
Feb 2, 2026 |
2025-0062 |
| Predicting eligibility for lung cancer screening |
Robert Volk |
University of Texas MD Anderson Cancer Center |
PLCO |
Jan 26, 2026 |
PLCO-2018 |
| Impact of a secondary biomarker on time-to-event risk prediction of prostate cancer mortality in a screening cohort |
Kristian Stensland |
The University of Michigan |
PLCO |
Jan 26, 2026 |
PLCO-2012 |
| Association between microplastic concentration in whole blood and risk of colorectal cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Rena Jones |
National Cancer Institute |
PLCO |
Jan 26, 2026 |
2025-0059 |
| Incidence Rates of Lung and Bladder Cancer According to Smoking Status and Tumor Subtype: An Analysis of Absolute Risk in Never Smokers |
Sarina Murray |
National Cancer Institute |
PLCO |
Jan 16, 2026 |
PLCO-2017 |
| PLCO Germline Materials for Integrated Whole-Genome Discovery of Lung Cancer Susceptibility with the Sherlock-Lung Study |
Maria Teresa Landi |
National Cancer Institute, National Institutes of Health |
PLCO |
Jan 15, 2026 |
PLCO-2016 |
| Evaluation of medical conditions associated with oral tongue cancer |
Anil Chaturvedi |
National Cancer Institute |
PLCO |
Jan 9, 2026 |
PLCO-2013 |
| Causal predictive modeling of survival of Breast cancer: A comparative study with machine learning, traditional survival modeling methods along and causal survival models |
Malinda Iluppangama |
Loyola University Maryland |
PLCO |
Jan 8, 2026 |
PLCO-2009 |
| PLCO Colorectal Cohort Tables for Outcome Labeling and WSI Linkage to Support Risk Modeling |
Yuming Jiang |
Wake Forest University Health Sciences |
PLCO |
Jan 7, 2026 |
PLCO-2006 |
| Developing a risk calculator for the early detection of prostate cancer |
Visalini Nair-Shalliker |
The Daffodil Centre, The University Sydney, and Cancer Council,NSW |
PLCO |
Dec 22, 2025 |
PLCO-1993 |
| Learning about the effectiveness of lung cancer screening in real-world target populations |
Sarah Robertson |
Dartmouth College |
PLCO |
Dec 22, 2025 |
PLCO-2005 |
| NSAID use and risk of ovarian and endometrial cancer |
Kaja Michalczyk |
Pomeranian Medical University |
PLCO |
Dec 22, 2025 |
PLCO-1988 |
| Evaluating Multi-trait PRS Methods on Cancer Phenotypes in PLCO |
Phillip Kraft |
National Cancer Institute |
PLCO |
Dec 16, 2025 |
PLCO-2004 |
| Developing Contextualized Cancer Risk Models: Integrating Polygenic Risk Scores with Environmental, Geospatial, and Social Determinants of Health Data |
Phillip Kraft |
National Cancer Institute |
PLCO |
Dec 16, 2025 |
PLCO-2003 |
| Comparative Analysis of Military Veteran Cancer Biomarkers Using the PLCO Dataset as a Civilian Control Cohort |
Chelsey Simoni |
HunterSeven Foundation |
PLCO |
Dec 10, 2025 |
PLCO-1989 |
| An investigation into modifiable causes of primary lymphoma of the digestive system: the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
Harindra Jayasekara |
Cancer Council Victoria |
PLCO |
Dec 5, 2025 |
PLCO-1995 |
| Identifying Proteomics Associated with Diet |
Steven Moore |
National Cancer Institute |
PLCO |
Dec 1, 2025 |
PLCO-2001 |
